2.03 USD
↘ 0.37 (15.40%)AT CLOSE (03:59 PM EDT)
Virax Biolabs Group Limited Ordinary Shares
VRAXNASDAQ • USD
2.07
↗ 0.04 (1.72%)
POST MARKET (AS OF 04:39 PM EDT)
Post Market
AS OF 04:39 PM EDT
2.07
↗ 0.04 (1.72%)
Market: OPEN
VRAX is currently priced at $2.07. The technical outlook is "Sell" based on moving average alignment, RSI, and MACD signals. Notable factors include a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment.
Technical & fundamental data as of Oct 5, 2026.
Open?$2.33
High?$2.33
Low?$1.83
Prev. Close?$2.40
Volume?309.5K
Avg. Volume?N/A
VWAP?$2.08
Bid / Ask
Bid?$1.65 × 100
Ask?$2.32 × 100
Spread?$0.67
Midpoint?$1.98
Valuation & Ratios
Market Cap?1.9M
Shares Out?796.9K
Float?7.0M
Float %?94.5%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
Virax Biolabs Group Ltd is a biotechnology company focused on the detection of immune responses and the development of immune profiling and in vitro diagnostic technologies for viral and immune-mediated diseases, with a current strategic focus on post-acute infection syndromes (PAIS) and related areas of chronic immune dysfunction. The company's principal development activities are centered on T cell-based in vitro diagnostics and immune profiling. The company's flagship product candidate, ViraxImmune, is an in-development T cell-based assay and immune profiling platform intended to support the assessment of immune dysfunction, initially in PAIS indications.
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental Outlook
Loading...
Short InterestLow
Short % of Float?0.43%Low
Short Interest?30.5K
Days to Cover?1.0
Free Float7.0M
Avg Daily Volume39.2K
Settlement Date2026-09-15